<DOC>
	<DOCNO>NCT00904111</DOCNO>
	<brief_summary>Patients Chronic Axial Low Back Pain participate Phase II clinical trial ass efficacy lidocaine 5 % patch compare placebo .</brief_summary>
	<brief_title>A Study Comparing The Efficacy And Safety Of Lidocaine 5 % Patch With Placebo In Patients With Chronic Axial Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Key Had axial LBP without radiation present least 3 month define : Chronic axial LBP without radiation : pain isolate axial low back without radiation buttock Chronic axial LBP radiation : pain radiate buttock . This patient group could include patient radicular/neuropathic nonradicular component leg pain component &lt; 50 % Had daily moderate severe LBP primary source pain Had normal neurological examination , include : Motor strength Sensory exam low extremity Deep tendon reflex Had normal 12lead electrocardiogram ( ECG ) without clinically significant abnormality heart rate , rhythm , conduction Had discontinue use analgesic medication ( include overthecounter [ OTC ] analgesic ) prior randomization ( patient allow limited use analgesic medication indication nonstudy pain ) . Had daily average pain intensity rating 6 great ( 0 10 scale ) least 3 day 5 consecutive day immediately prior baseline visit ; 0 define `` pain '' 10 define `` pain bad ever imagine '' measure Question 5 Brief Pain Inventory ( BPI ) record diary Key Had spinal stenosis &gt; 50 % leg pain component Had elective surgery schedule occur 14week study Had history one back surgery within 1 year study entry Had severe renal insufficiency ( creatinine clearance &lt; 30mL/min ) Had moderate great hepatic impairment Were take analgesic medication could discontinue study . Patients take medication prior study require discontinue use duration study . Patients use opioid analgesic study entry require taper medication . Were take longacting opioids opioids could discontinue first 5 day placebo runin period Had receive epidural steroid/local anesthesia injection within 4 week prior study entry Had receive trigger point injection within 2 week prior study entry Had receive Botulinum Toxin ( Botox ) Injections LBP within 6 month prior study entry Were use lidocainecontaining product could discontinue study Were use topical medication apply low back region Had previously fail treatment Lidoderm analgesic patch LBP Were take class 1 antiarrhythmic drug ( e.g . mexiletine , tocainide ) Had chronic pain condition , opinion investigator , would interfere patient assessment LBP relief</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>